Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
K-757 Alone and in Combination With K-833 for Weight Loss in Obesity
NCT06019559Phase 2Completed
- Sponsor
- Kallyope
- Start
- Sep 2023
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of K757, K-833 in obesity, sponsored by Kallyope. Started Sep 2023; status: completed.
02
Drugs
K757K-833
03
Conditions
obesity
Beyond the preview
Go deeper on NCT06019559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06019559.